SPRINGFIELD, Ill. (WAND) — A state Democratic bill to make it faster to receive some HIV medication passed the Illinois House ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...

From the column: "This is a four-alarm fire. ... Let’s take a page from the early days of HIV advocacy and remember, silence ...

The U.S. Supreme Court is gearing up to hear Kennedy v. Braidwood Management Inc., a case that could effectively sever access to cost-free preventive care services — including PrEP.

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other institutions, have successfully ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...

In part 1 of this interview with Katrina Ortblad, ScD, MPH, she addressed bridging gaps in HIV care with pharmacy-based ...

This type of submission refers to analyses conducted via computer simulation, allowing researchers to predict how TH104 will work as a prophylaxis against opioid exposure. Specifically ...

This type of submission refers to analyses conducted via computer simulation, allowing researchers to predict how TH104 will work as a prophylaxis against opioid exposure. Specifically, by inputting ...

House Bill 2769, titled Life or Health Insurances; Unfair Discrimination, Pre-Exposure Prophylaxis for Prevention of HIV, was passed by both chambers of the Virginia General Assembly. The bill cleared ...

referring to the network that helped lead to the development of pre-exposure prophylaxis, or PrEP, which people at risk for HIV can take to prevent infection. Other ongoing studies funded by the ...